{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T22:23:31Z","timestamp":1791757411130,"version":"4.3.4"},"reference-count":195,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004329","name":"The Slovenian Research and Innovation Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Chronic inflammation underlies a broad range of human diseases, including autoimmune disorders, neurodegeneration, and metabolic syndromes. While acute inflammation is essential for pathogen clearance and tissue repair, persistent activation leads to tissue damage and disease progression. Two key innate immune pathways, the complement system and inflammasomes, are crucial mediators of inflammation and are increasingly recognized as interdependent effectors that sustain chronic inflammatory states. This review examines the mechanistic crosstalk between complement activation and inflammasome signaling, with an emphasis on the NLRP3 inflammasome. We first outline how complement pathways drive inflammation through cell recruitment, cytokine induction, and failure of regulatory checkpoints. Next, we review the triggers, regulation, and persistence of inflammasome activation, highlighting the central role of NLRP3 and its engagement by diverse danger signals in chronic disease. In the main section, we detail multiple mechanistic intersections between the two systems, including shared activation triggers such as reactive oxygen species and mitochondrial damage, direct priming and activation of inflammasomes by complement components (e.g., C3a, C5a, MAC), and feedback loops driven by inflammasome-derived cytokines (IL-1\u03b2, IL-18) that enhance complement activity and immune cell recruitment. We further illustrate these interactions across disease contexts, including gout, atherosclerosis, rheumatoid arthritis, systemic lupus erythematosus, and Alzheimer\u2019s disease. In each case, complement and inflammasomes form a self-amplifying loop that exacerbates inflammation and tissue damage. We also examine the dual role of C1q as both an enhancer and suppressor of inflammasome activation, depending on the cellular and molecular environment. Finally, we discuss therapeutic strategies targeting these pathways. Complement inhibitors (e.g., eculizumab, avacopan), inflammasome inhibitors (e.g., MCC950), and IL-1\u03b2 blockers (anakinra) show clinical promise, and dual-targeting approaches may offer synergistic benefit. Understanding the interplay between complement and inflammasomes provides critical insight into the persistence of inflammation and opens new avenues for precise immunomodulation in chronic diseases.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1778759","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T04:10:33Z","timestamp":1774843833000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Complement and inflammasome crosstalk in chronic inflammation"],"prefix":"10.3389","volume":"17","author":[{"given":"Larisa","family":"Jan\u017ei\u010d","sequence":"first","affiliation":[{"name":"Institute of microbiology and immunology, Faculty of medicine, University of Ljubljana","place":["Ljubljana, Slovenia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina","family":"Kouter","sequence":"additional","affiliation":[{"name":"Institute of microbiology and immunology, Faculty of medicine, University of Ljubljana","place":["Ljubljana, Slovenia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0675-0","article-title":"Chronic inflammation in the etiology of disease across the life span","volume":"25","author":"Furman","year":"2019","journal-title":"Nat Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.30574\/gscarr.2025.24.2.0238","article-title":"The dual nature of inflammation: From essential host defense to driver of chronic disease: A review","volume":"24","author":"Chukwuebuka Chukwuezugolum","year":"2025","journal-title":"GSC Advanced Res Rev"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/imm.12556","article-title":"Complementing the inflammasome","volume":"147","author":"Triantafilou","year":"2016","journal-title":"Immunology"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201546131","article-title":"A novel \u201ccomplement-metabolism-inflammasome axis\u201d as a key regulator of immune cell effector function","volume":"46","author":"Arbore","year":"2016","journal-title":"Eur J Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3893","article-title":"Inflammasomes: mechanism of action, role in disease, and therapeutics","volume":"21","author":"Guo","year":"2015","journal-title":"Nat Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1682306","article-title":"Cytokines in sepsis: a critical review of the literature on systemic inflammation and multiple organ dysfunction","volume":"16","author":"Vella","year":"2025","journal-title":"Front Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1006\/jsre.1998.5503","article-title":"Complement component C3 production in IL-1beta-stimulated human intestinal epithelial cells is blocked by NF-kappaB inhibitors and by transfection with ser 32\/36 mutant IkappaBalpha","volume":"82","author":"Moon","year":"1999","journal-title":"J Surg Res"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.156.11.4429","article-title":"IFN-gamma up-regulates expression of the complement components C3 and C4 by stabilization of mRNA","volume":"156","author":"Mitchell","year":"1996","journal-title":"J Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"8119","DOI":"10.3390\/ijms25158119","article-title":"The establishment of complement system is from gene duplication and domain shuffling","volume":"25","author":"Sun","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B10","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/cr.2009.139","article-title":"Complement and its role in innate and adaptive immune responses","volume":"20","author":"Dunkelberger","year":"2010","journal-title":"Cell Res"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-023-00926-1","article-title":"A guide to complement biology, pathology and therapeutic opportunity","volume":"24","author":"Mastellos","year":"2024","journal-title":"Nat Rev Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.2147\/ITT.S305420","article-title":"The role of complement in synaptic pruning and neurodegeneration","volume":"10","author":"Gomez-Arboledas","year":"2021","journal-title":"Immunotargets Ther"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-020-0400-0","article-title":"Complement in neurological disorders and emerging complement-targeted therapeutics","volume":"16","author":"Dalakas","year":"2020","journal-title":"Nat Rev Neurol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01308","article-title":"Complement nomenclature-deconvoluted","volume":"10","author":"Bohlson","year":"2019","journal-title":"Front Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41467-023-36068-0","article-title":"The classical pathway triggers pathogenic complement activation in membranous nephropathy","volume":"14","author":"Seifert","year":"2023","journal-title":"Nat Commun"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25031566","article-title":"The lectin pathway of the complement system-activation, regulation, disease connections and interplay with other (Proteolytic) systems","volume":"25","author":"Dob\u00f3","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B17","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/imr.13130","article-title":"Initiation of the alternative pathway of complement and the history of \u201ctickover","volume":"313","author":"Pangburn","year":"2023","journal-title":"Immunol Rev"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00262","article-title":"Complement system part I \u2013 molecular mechanisms of activation and regulation","volume":"6","author":"Merle","year":"2015","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/imr.13172","article-title":"The complement alternative pathway in health and disease\u2014activation or amplification","volume":"313","author":"Harrison","year":"2023","journal-title":"Immunol Rev"},{"key":"B20","doi-asserted-by":"publisher","first-page":"115878","DOI":"10.1016\/j.biopha.2023.115878","article-title":"Complement-pentraxins synergy: Navigating the immune battlefield and beyond","volume":"169","author":"Ma","year":"2023","journal-title":"BioMed Pharmacother"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2017.51","article-title":"An overview of the synergy and crosstalk between pentraxins and collectins\/ficolins: their functional relevance in complement activation","volume":"49","author":"Ma","year":"2017","journal-title":"Exp Mol Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01750","article-title":"Regulation of the complement system by pentraxins","volume":"10","author":"Haapasalo","year":"2019","journal-title":"Front Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2020.02.006","article-title":"Complement membrane attack complex: new roles, mechanisms of action, and therapeutic targets","volume":"190","author":"Xie","year":"2020","journal-title":"Am J Pathol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awz222","article-title":"Targeting the complement system in bacterial meningitis","volume":"142","author":"Koelman","year":"2019","journal-title":"Brain"},{"key":"B25","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/nrneph.2017.156","article-title":"The renaissance of complement therapeutics","volume":"14","author":"Ricklin","year":"2018","journal-title":"Nat Rev Nephrol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.42671","article-title":"Complement","volume":"76","author":"Monach","year":"2024","journal-title":"Arthritis Rheumatol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2013.08.001","article-title":"Overview of complement activation and regulation","volume":"33","author":"Noris","year":"2013","journal-title":"Semin Nephrol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-023-00704-1","article-title":"Complosome \u2014 the intracellular complement system","volume":"19","author":"West","year":"2023","journal-title":"Nat Rev Nephrol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.molimm.2017.05.012","article-title":"Intracellular complement - the complosome - in immune cell regulation","volume":"89","author":"Arbore","year":"2017","journal-title":"Mol Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3390\/cells14120930","article-title":"Inflammasomes and signaling pathways: key mechanisms in the pathophysiology of sepsis","volume":"14","author":"Saavedra-Torres","year":"2025","journal-title":"Cells"},{"key":"B31","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41392-023-01687-y","article-title":"The role of inflammasomes in human diseases and their potential as therapeutic targets","volume":"9","author":"Yao","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3390\/cells12131766","article-title":"Inflammasomes: mechanisms of action and involvement in human diseases","volume":"12","author":"Bult\u00e9","year":"2023","journal-title":"Cells"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-024-01261-8","article-title":"NLRP3 inflammasome: a key player in the pathogenesis of life-style disorders","volume":"56","author":"Ramachandran","year":"2024","journal-title":"Exp Mol Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-025-01354-y","article-title":"Molecular mechanisms and regulation of inflammasome activation and signaling: sensing of pathogens and damage molecular patterns","volume":"22","author":"Dubey","year":"2025","journal-title":"Cell Mol Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s11658-023-00462-9","article-title":"The NLRP3 inflammasome: contributions to inflammation-related diseases","volume":"28","author":"Chen","year":"2023","journal-title":"Cell Mol Biol Lett"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.108936","article-title":"The interleukin 1 inhibitor rilonacept in treatment of chronic gouty arthritis: results of a placebo-controlled, monosequence crossover, non-randomised, single-blind pilot study","volume":"68","author":"Terkeltaub","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"B37","doi-asserted-by":"publisher","first-page":"39","DOI":"10.2147\/JIR.S11330","article-title":"The role of the NLRP3 inflammasome in gout","volume":"4","author":"Kingsbury","year":"2011","journal-title":"J Inflammation Res"},{"key":"B38","article-title":"NLRP3 inflammasome is essential for the development of chronic obstructive pulmonary disease","volume":"8","author":"Yang","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12973","article-title":"NLRP3 regulates alveolar bone loss in ligature-induced periodontitis by promoting osteoclastic differentiation","volume":"54","author":"Chen","year":"2021","journal-title":"Cell Prolif"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204361","article-title":"Somatic NLRP3 mosaicism in Muckle-Wells syndrome. A genetic mechanism shared by different phenotypes of cryopyrin-associated periodic syndromes","volume":"74","author":"Nakagawa","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"B41","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.jaci.2019.05.034","article-title":"A novel knock-in mouse model of cryopyrin-associated periodic syndromes with development of amyloidosis: Therapeutic efficacy of proton pump inhibitors","volume":"145","author":"Bertoni","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20082481","article-title":"In vivo regulation of interleukin 1beta in patients with cryopyrin-associated periodic syndromes","volume":"206","author":"Lachmann","year":"2009","journal-title":"J Exp Med"},{"key":"B43","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41421-020-0167-x","article-title":"Inflammasome activation and regulation: toward a better understanding of complex mechanisms","volume":"6","author":"Zheng","year":"2020","journal-title":"Cell Discov"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1113883","article-title":"Caspase-11 promotes high-fat diet-induced NAFLD by increasing glycolysis, OXPHOS, and pyroptosis in macrophages","volume":"14","author":"Drummer","year":"2023","journal-title":"Front Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.2337\/db06-1491","article-title":"Metabolic endotoxemia initiates obesity and insulin resistance","volume":"56","author":"Cani","year":"2007","journal-title":"Diabetes"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-018-0082-x","article-title":"The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"16","author":"Kazankov","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20211405","article-title":"Human NLRP1: From the shadows to center stage","volume":"219","author":"Bauernfried","year":"2021","journal-title":"J Exp Med"},{"key":"B48","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12969-022-00728-0","article-title":"Pathophysiology, clinical manifestations and current management of IL-1 mediated monogenic systemic autoinflammatory diseases, a literature review","volume":"20","author":"Li","year":"2022","journal-title":"Pediatr Rheumatol Online J"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1093\/bjd\/ljad421","article-title":"Role of the NLRP1 inflammasome in skin cancer and inflammatory skin diseases","volume":"190","author":"Calabrese","year":"2023","journal-title":"Br J Dermatol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"102298","DOI":"10.1016\/j.mib.2023.102298","article-title":"Human and mouse NAIP\/NLRC4 inflammasome responses to bacterial infection","volume":"73","author":"Egan","year":"2023","journal-title":"Curr Opin Microbiol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00309","article-title":"Emerging concepts about NAIP\/NLRC4 inflammasomes","volume":"5","author":"Lage","year":"2014","journal-title":"Front Immunol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12969-024-01020-z","article-title":"Three cases of autoinflammatory disease with novel NLRC4 mutations, and the first mutation reported in the CARD domain of NLRC4 associated with autoinflammatory infantile enterocolitis (AIFEC)","volume":"22","author":"Asna Ashari","year":"2024","journal-title":"Pediatr Rheumatol Online J"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3089","article-title":"An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome","volume":"46","author":"Canna","year":"2014","journal-title":"Nat Genet"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.674808","article-title":"A novel mutation in the NBD domain of NLRC4 causes mild autoinflammation with recurrent urticaria","volume":"12","author":"Wang","year":"2021","journal-title":"Front Immunol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/nature07725","article-title":"AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC","volume":"458","author":"Hornung","year":"2009","journal-title":"Nature"},{"key":"B56","doi-asserted-by":"publisher","first-page":"82ra38","DOI":"10.1126\/scitranslmed.3002001","article-title":"Cytosolic DNA triggers inflammasome activation in keratinocytes in psoriatic lesions","volume":"3","author":"Dombrowski","year":"2011","journal-title":"Sci Transl Med"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.171894","article-title":"The DNA sensor AIM2 mediates psoriasiform inflammation by inducing type 3 immunity","volume":"9","author":"Varela Martins","year":"2024","journal-title":"JCI Insight"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.155563","article-title":"The AIM2 inflammasome is activated in astrocytes during the late phase of EAE","volume":"7","author":"Barclay","year":"2022","journal-title":"JCI Insight"},{"key":"B59","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.cell.2015.06.001","article-title":"Critical role for the DNA sensor AIM2 in stem cell proliferation and cancer","volume":"162","author":"Man","year":"2015","journal-title":"Cell"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.micinf.2013.04.001","article-title":"NLRP7 and related inflammasome activating pattern recognition receptors and their function in host defense and disease","volume":"15","author":"Radian","year":"2013","journal-title":"Microbes Infect"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1111\/imm.13372","article-title":"NLRP7: From inflammasome regulation to human disease","volume":"163","author":"Carriere","year":"2021","journal-title":"Immunology"},{"key":"B62","doi-asserted-by":"publisher","first-page":"175995","DOI":"10.1016\/j.ejphar.2023.175995","article-title":"The role of NLRP12 in inflammatory diseases","volume":"956","author":"Huang","year":"2023","journal-title":"Eur J Pharmacol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/kzggp3","article-title":"NLRP12-associated autoinflammatory disease: much more than the FCAS phenotype","volume":"41","author":"Demir","year":"2023","journal-title":"Clin Exp Rheumatol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2021-001824","article-title":"Contrasting role of NLRP12 in autoinflammation: evidence from a case report and mouse models","volume":"7","author":"Levy","year":"2021","journal-title":"RMD Open"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2011.10.022","article-title":"The NOD-like receptor NLRP12 attenuates colon inflammation and tumorigenesis","volume":"20","author":"Zaki","year":"2011","journal-title":"Cancer Cell"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1103760","article-title":"Complement protein C1q directs macrophage polarization and limits inflammasome activity during the uptake of apoptotic cells","volume":"188","author":"Benoit","year":"2012","journal-title":"J Immunol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01745","article-title":"The pyrin inflammasome in health and disease","volume":"10","author":"Schnappauf","year":"2019","journal-title":"Front Immunol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3457","article-title":"Pyrin inflammasome activation and RhoA signaling in the autoinflammatory diseases FMF and HIDS","volume":"17","author":"Park","year":"2016","journal-title":"Nat Immunol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.mib.2020.01.005","article-title":"The pyrin inflammasome in host-microbe interactions","volume":"54","author":"Loeven","year":"2020","journal-title":"Curr Opin Microbiol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1341680","article-title":"The pyrin inflammasome, a leading actor in pediatric autoinflammatory diseases","volume":"14","author":"La Bella","year":"2023","journal-title":"Front Immunol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.172975","article-title":"A dominant pathogenic MEFV mutation causes atypical pyrin-associated periodic syndromes","volume":"8","author":"Wang","year":"2023","journal-title":"JCI Insight"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00971","article-title":"The use of interleukine-1 inhibitors in familial mediterranean fever patients: A narrative review","volume":"11","author":"Hentgen","year":"2020","journal-title":"Front Immunol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1300489","article-title":"Cutting edge: the NLRP3 inflammasome links complement-mediated inflammation and IL-1beta release","volume":"191","author":"Laudisi","year":"2013","journal-title":"J Immunol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s12015-019-09888-1","article-title":"ATP-nlrp3 inflammasome-complement cascade axis in sterile brain inflammation in psychiatric patients and its impact on stem cell trafficking","volume":"15","author":"Ratajczak","year":"2019","journal-title":"Stem Cell Rev Rep"},{"key":"B75","doi-asserted-by":"publisher","first-page":"aad1210","DOI":"10.1126\/science.aad1210","article-title":"T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4+ T cells","volume":"352","author":"Arbore","year":"2016","journal-title":"Science"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.720655","article-title":"Internalization of the membrane attack complex triggers NLRP3 inflammasome activation and IL-1beta secretion in human macrophages","volume":"12","author":"Diaz-Del-Olmo","year":"2021","journal-title":"Front Immunol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.918551","article-title":"Complement membrane attack complex is an immunometabolic regulator of NLRP3 activation and IL-18 secretion in human macrophages","volume":"13","author":"Jimenez-Duran","year":"2022","journal-title":"Front Immunol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.179291","article-title":"Complement-mediated \u2018bystander\u2019 damage initiates host NLRP3 inflammasome activation","volume":"129","author":"Suresh","year":"2016","journal-title":"J Cell Sci"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.139.3.794","article-title":"C3a(C3adesArg) induces production and release of interleukin 1 by cultured human monocytes","volume":"139","author":"Haeffner-Cavaillon","year":"1987","journal-title":"J Immunol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-05-502229","article-title":"C3a modulates IL-1beta secretion in human monocytes by regulating ATP efflux and subsequent NLRP3 inflammasome activation","volume":"122","author":"Asgari","year":"2013","journal-title":"Blood"},{"key":"B81","doi-asserted-by":"publisher","first-page":"102985","DOI":"10.1016\/j.ebiom.2020.102985","article-title":"Cholesterol crystals use complement to increase NLRP3 signaling pathways in coronary and carotid atherosclerosis","volume":"60","author":"Niyonzima","year":"2020","journal-title":"EBioMedicine"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1302484","article-title":"Cholesterol crystals induce complement-dependent inflammasome activation and cytokine release","volume":"192","author":"Samstad","year":"2014","journal-title":"J Immunol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"493","DOI":"10.3892\/etm.2022.11420","article-title":"The complement C3a-C3aR and C5a-C5aR pathways promote viability and inflammation of human retinal pigment epithelium cells by targeting NF-kappaB signaling","volume":"24","author":"Luo","year":"2022","journal-title":"Exp Ther Med"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1159\/000538241","article-title":"The complement C3a and C5a signaling in renal diseases: A bridge between acute and chronic inflammation","volume":"148","author":"Buelli","year":"2024","journal-title":"Nephron"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0827-8","article-title":"The Nlrp3 inflammasome as a \u201crising star\u201d in studies of normal and Malignant hematopoiesis","volume":"34","author":"Ratajczak","year":"2020","journal-title":"Leukemia"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201444560","article-title":"Complement C5a potentiates uric acid crystal-induced IL-1beta production","volume":"44","author":"An","year":"2014","journal-title":"Eur J Immunol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abf2489","article-title":"Mitochondrial C5aR1 activity in macrophages controls IL-1beta production underlying sterile inflammation","volume":"6","author":"Niyonzima","year":"2021","journal-title":"Sci Immunol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"102336","DOI":"10.1016\/j.jaut.2019.102336","article-title":"Complement C1q synergizes with PTX3 in promoting NLRP3 inflammasome over-activation and pyroptosis in rheumatoid arthritis","volume":"106","author":"Wu","year":"2020","journal-title":"J Autoimmunity"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.816839","article-title":"Inflammasome and its therapeutic targeting in rheumatoid arthritis","volume":"12","author":"Jiang","year":"2021","journal-title":"Front Immunol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/j.tins.2023.11.010","article-title":"Complement-mediated synapse loss in Alzheimer\u2019s disease: mechanisms and involvement of risk factors","volume":"47","author":"Wen","year":"2024","journal-title":"Trends Neurosciences"},{"key":"B91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/157015909787602805","article-title":"Implication of complement system and its regulators in Alzheimer\u2019s disease","volume":"7","author":"Kolev","year":"2009","journal-title":"Curr Neuropharmacol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1126\/science.aad8373","article-title":"Complement and microglia mediate early synapse loss in Alzheimer mouse models","volume":"352","author":"Hong","year":"2016","journal-title":"Science"},{"key":"B93","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/s41398-025-03458-5","article-title":"Complement C1q is associated with neuroinflammation and mediates the association between amyloid-\u03b2 and tau pathology in Alzheimer\u2019s disease","volume":"15","author":"Guo","year":"2025","journal-title":"Transl Psychiatry"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.3RI0615-239R","article-title":"Parainflammation, chronic inflammation, and age-related macular degeneration","volume":"98","author":"Chen","year":"2015","journal-title":"J Leukoc Biol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.3390\/jcm4010172","article-title":"NLRP3 inflammasome and pathobiology in AMD","volume":"4","author":"Celkova","year":"2015","journal-title":"J Clin Med"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1186\/ar301","article-title":"Links between complement deficiency and apoptosis","volume":"3","author":"Botto","year":"2001","journal-title":"Arthritis Res"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00402","article-title":"Complement, c1q, and c1q-related molecules regulate macrophage polarization","volume":"5","author":"Bohlson","year":"2014","journal-title":"Front Immunol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1001731","article-title":"C1q deficiency leads to the defective suppression of IFN-alpha in response to nucleoprotein containing immune complexes","volume":"185","author":"Santer","year":"2010","journal-title":"J Immunol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"key":"B100","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/nature10510","article-title":"The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus","volume":"477","author":"Zhao","year":"2011","journal-title":"Nature"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01450","article-title":"Viral evasion of the complement system and its importance for vaccines and therapeutics","volume":"11","author":"Mellors","year":"2020","journal-title":"Front Immunol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1247377","article-title":"Inflammasome activation by viral infection: mechanisms of activation and regulation","volume":"14","author":"Shi","year":"2023","journal-title":"Front Microbiol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1016\/j.jid.2019.12.035","article-title":"ATP-P2X7-induced inflammasome activation contributes to melanocyte death and CD8(+) T-cell trafficking to the skin in vitiligo","volume":"140","author":"Ahn","year":"2020","journal-title":"J Invest Dermatol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.3390\/biology13060431","article-title":"Double-edged sword: exploring the mitochondria-complement bidirectional connection in cellular response and disease","volume":"13","author":"Lin","year":"2024","journal-title":"Biol (Basel)"},{"key":"B105","doi-asserted-by":"publisher","first-page":"3462530","DOI":"10.1155\/2019\/3462530","article-title":"ER stress activates the NLRP3 inflammasome: A novel mechanism of atherosclerosis","volume":"2019","author":"Chen","year":"2019","journal-title":"Oxid Med Cell Longev"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2014.05.004","article-title":"Oxidative post-translational modifications and their involvement in the pathogenesis of autoimmune diseases","volume":"2","author":"Ryan","year":"2014","journal-title":"Redox Biol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"39884","DOI":"10.1038\/srep39884","article-title":"Soluble uric acid activates the NLRP3 inflammasome","volume":"7","author":"Braga","year":"2017","journal-title":"Sci Rep"},{"key":"B108","doi-asserted-by":"publisher","first-page":"41000","DOI":"10.1038\/s41598-025-24705-1","article-title":"Extracellular mitochondrial DNA activates complement and is associated with complement activation in patients with out-of-hospital cardiac arrest","volume":"15","author":"de Boer","year":"2025","journal-title":"Sci Rep"},{"key":"B109","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3892\/ijmm.2022.5130","article-title":"Focus on the role of mitochondria in NLRP3 inflammasome activation: A prospective target for the treatment of ischemic stroke","volume":"49","author":"Zhang","year":"2022","journal-title":"Int J Mol Med"},{"key":"B110","volume-title":"The autoimmune diseases","author":"Rose","year":"2020"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1631","article-title":"Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization","volume":"9","author":"Hornung","year":"2008","journal-title":"Nat Immunol"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(77)90133-6","article-title":"Activation of the alternative complement pathway and generation of chemotactic factors by asbestos","volume":"60","author":"Wilson","year":"1977","journal-title":"J Allergy Clin Immunol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1016\/S0013-9351(86)80105-0","article-title":"The role of complement in experimental silicosis","volume":"40","author":"Callis","year":"1986","journal-title":"Environ Res"},{"key":"B114","doi-asserted-by":"publisher","first-page":"1340156","DOI":"10.1155\/2016\/1340156","article-title":"Bidirectional crosstalk between C5a receptors and the NLRP3 inflammasome in macrophages and monocytes","volume":"2016","author":"Haggadone","year":"2016","journal-title":"Mediators Inflamm"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1038\/nature08938","article-title":"NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals","volume":"464","author":"Duewell","year":"2010","journal-title":"Nature"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11020261","article-title":"Neutrophil extracellular traps and NLRP3 inflammasome: A disturbing duo in atherosclerosis, inflammation and atherothrombosis","volume":"11","author":"Singh","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00010","article-title":"C5a regulates IL-1beta production and leukocyte recruitment in a murine model of monosodium urate crystal-induced peritonitis","volume":"8","author":"Khameneh","year":"2017","journal-title":"Front Pharmacol"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0189017","article-title":"C5a and C5aR are elevated in joints of rheumatoid and psoriatic arthritis patients, and C5aR blockade attenuates leukocyte migration to synovial fluid","volume":"12","author":"Hornum","year":"2017","journal-title":"PloS One"},{"key":"B119","doi-asserted-by":"publisher","first-page":"cm1","DOI":"10.1126\/scisignal.3105cm1","article-title":"Interleukin-1 (IL-1) pathway","volume":"3","author":"Weber","year":"2010","journal-title":"Sci Signal"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.3171\/spi.2005.2.5.0589","article-title":"Positive feedback loop of interleukin-1beta upregulating production of inflammatory mediators in human intervertebral disc cells in vitro","volume":"2","author":"Jimbo","year":"2005","journal-title":"J Neurosurg Spine"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201801513R","article-title":"Critical role of IL-1\u03b1 in IL-1\u03b2-induced inflammatory responses: cooperation with NF-\u03baBp65 in transcriptional regulation","volume":"33","author":"Singh","year":"2019","journal-title":"FASEB J"},{"key":"B122","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.ejcb.2011.09.008","article-title":"Hepatic acute phase proteins \u2013 Regulation by IL-6- and IL-1-type cytokines involving STAT3 and its crosstalk with NF-\u03baB-dependent signaling","volume":"91","author":"Bode","year":"2012","journal-title":"Eur J Cell Biol"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.1997.01430360035007","article-title":"Complement C3 production in human intestinal epithelial cells is regulated by interleukin 1beta and tumor necrosis factor alpha","volume":"132","author":"Moon","year":"1997","journal-title":"Arch Surg"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.919973","article-title":"Interleukin-18 cytokine in immunity, inflammation, and autoimmunity: Biological role in induction, regulation, and treatment","volume":"13","author":"Ihim","year":"2022","journal-title":"Front Immunol"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252413505","article-title":"IL-18 and IL-18BP: A unique dyad in health and disease","volume":"25","author":"Novick","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2004.10.020","article-title":"IFN-\u03b3 primes macrophages for enhanced TNF-\u03b1 expression in response to stimulatory and non-stimulatory amounts of microparticulate \u03b2-glucan","volume":"98","author":"Berner","year":"2005","journal-title":"Immunol Letters"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-061813-012806","article-title":"Pathogenesis of macrophage activation syndrome and potential for cytokine- directed therapies","volume":"66","author":"Schulert","year":"2015","journal-title":"Annu Rev Med"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-12-820852","article-title":"Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome","volume":"131","author":"Weiss","year":"2018","journal-title":"Blood"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01250","article-title":"Analysis of serum interleukin (IL)-1beta and IL-18 in systemic lupus erythematosus","volume":"9","author":"Mende","year":"2018","journal-title":"Front Immunol"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2009.04742.x","article-title":"IL-18 activity in systemic lupus erythematosus","volume":"1173","author":"Favilli","year":"2009","journal-title":"Ann New York Acad Sci"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.119.314845","article-title":"Complement membrane attack complexes assemble NLRP3 inflammasomes triggering IL-1 activation of IFN-gamma-primed human endothelium","volume":"124","author":"Xie","year":"2019","journal-title":"Circ Res"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1102048","article-title":"IL-1\u03b1 and IL-1\u03b2 Recruit different myeloid cells and promote different stages of sterile inflammation","volume":"187","author":"Rider","year":"2011","journal-title":"J Immunol"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-025-01358-8","article-title":"IL-1 family cytokines in inflammation and immunity","volume":"22","author":"Garlanda","year":"2025","journal-title":"Cell Mol Immunol"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2024.03.002","article-title":"DAMPs and DAMP-sensing receptors in inflammation and diseases","volume":"57","author":"Ma","year":"2024","journal-title":"Immunity"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64461-6","article-title":"Generation of C5a by phagocytic cells","volume":"161","author":"Huber-Lang","year":"2002","journal-title":"Am J Pathol"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26062789","article-title":"The crosstalk between NETs and the complement cascade: an overview in nephrological autoimmune disease","volume":"26","author":"Kajana","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12361","article-title":"Impaired cytokine responses in patients with cryopyrin-associated periodic syndrome (CAPS)","volume":"177","author":"Haverkamp","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)17401-1","article-title":"Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist","volume":"364","author":"Hoffman","year":"2004","journal-title":"Lancet"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.3390\/biom15081179","article-title":"Complement cascades and brain disorders","volume":"15","author":"Jov\u010devska","year":"2025","journal-title":"Biomolecules"},{"key":"B140","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.3390\/biom15091344","article-title":"NLRP3 inflammasome in stress-related neuropsychiatric disorders: mechanisms of neuron\u2013microglia\u2013astrocyte crosstalk, HPA axis dysregulation, and therapeutic perspective","volume":"15","author":"Wo\u017any-Rasa\u0142a","year":"2025","journal-title":"Biomolecules"},{"key":"B141","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12974-022-02565-0","article-title":"Astrocytic and microglial cells as the modulators of neuroinflammation in Alzheimer\u2019s disease","volume":"19","author":"Singh","year":"2022","journal-title":"J Neuroinflammation"},{"key":"B142","doi-asserted-by":"publisher","first-page":"109941","DOI":"10.1016\/j.neuropharm.2024.109941","article-title":"NLRP3 inflammasome signalling in Alzheimer\u2019s disease","volume":"252","author":"McManus","year":"2024","journal-title":"Neuropharmacology"},{"key":"B143","doi-asserted-by":"publisher","first-page":"13647","DOI":"10.3390\/ijms222413647","article-title":"Complement system in alzheimer\u2019s disease","volume":"22","author":"Shah","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1769-z","article-title":"NLRP3 inflammasome activation drives tau pathology","volume":"575","author":"Ising","year":"2019","journal-title":"Nature"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22031093","article-title":"Decoding mast cell-microglia communication in neurodegenerative diseases","volume":"22","author":"Sandhu","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2019.03.003","article-title":"IL-18 induced IL-23\/IL-17 expression impairs A\u03b2 clearance in cultured THP-1 and BV2 cells","volume":"119","author":"Chen","year":"2019","journal-title":"Cytokine"},{"key":"B147","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/1742-2094-9-199","article-title":"Pro-inflammatory interleukin-18 increases Alzheimer\u2019s disease-associated amyloid-\u03b2 production in human neuron-like cells","volume":"9","author":"Sutinen","year":"2012","journal-title":"J Neuroinflammation"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abl4024","article-title":"Mitochondrial uncoupling protein 1 antagonizes atherosclerosis by blocking NLRP3 inflammasome-dependent interleukin-1\u03b2 production","volume":"7","author":"Gu","year":"2021","journal-title":"Sci Adv"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1126\/science.abg3067","article-title":"Olfactory receptor 2 in vascular macrophages drives atherosclerosis by NLRP3-dependent IL-1 production","volume":"375","author":"Orecchioni","year":"2022","journal-title":"Science"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2010.04172.x","article-title":"Complement in atherosclerosis: friend or foe","volume":"9","author":"Speidl","year":"2011","journal-title":"J Thromb Haemost"},{"key":"B151","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.atherosclerosis.2022.03.014","article-title":"The multifaceted impact of complement on atherosclerosis","volume":"351","author":"Kiss","year":"2022","journal-title":"Atherosclerosis"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2020.06.015","article-title":"Advances in our understanding of gout as an auto-inflammatory disease","volume":"50","author":"Bodofsky","year":"2020","journal-title":"Semin Arthritis Rheumatism"},{"key":"B153","doi-asserted-by":"publisher","first-page":"4483","DOI":"10.1038\/s41598-022-08311-z","article-title":"Natural antibodies and CRP drive anaphylatoxin production by urate crystals","volume":"12","author":"Wessig","year":"2022","journal-title":"Sci Rep"},{"key":"B154","doi-asserted-by":"publisher","first-page":"R172","DOI":"10.1186\/ar208","article-title":"The proinflammatory cytokines IL-1beta and TNF-alpha induce the expression of Synoviolin, an E3 ubiquitin ligase, in mouse synovial fibroblasts via the Erk1\/2-ETS1 pathway","volume":"8","author":"Gao","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-07-273417","article-title":"Interleukin-1 in the pathogenesis and treatment of inflammatory diseases","volume":"117","author":"Dinarello","year":"2011","journal-title":"Blood"},{"key":"B156","doi-asserted-by":"publisher","first-page":"8360 p","DOI":"10.3390\/ijms25158360","article-title":"Complete description of the three pathways of the complement system in a series of 430 patients with rheumatoid arthritis","volume":"25","author":"Rodr\u00edguez-Gonz\u00e1lez","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01057","article-title":"Complement in the initiation and evolution of rheumatoid arthritis","volume":"9","author":"Holers","year":"2018","journal-title":"Front Immunol"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12186022","article-title":"From innate immunity to metabolic disorder: A review of the NLRP3 inflammasome in diabetes mellitus","volume":"12","author":"Nitulescu","year":"2023","journal-title":"J Clin Med"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.3390\/biom9120850","article-title":"Modulatory mechanisms of the NLRP3 inflammasomes in diabetes","volume":"9","author":"Ding","year":"2019","journal-title":"Biomolecules"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1831","article-title":"Thioredoxin-interacting protein links oxidative stress to inflammasome activation","volume":"11","author":"Zhou","year":"2010","journal-title":"Nat Immunol"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2279","article-title":"The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance","volume":"17","author":"Vandanmagsar","year":"2011","journal-title":"Nat Med"},{"key":"B162","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4239\/wjd.v11.i1.1","article-title":"Complement activation in obesity, insulin resistance, and type 2 diabetes mellitus","volume":"11","author":"Shim","year":"2020","journal-title":"World J Diabetes"},{"key":"B163","doi-asserted-by":"publisher","first-page":"108739","DOI":"10.1016\/j.intimp.2022.108739","article-title":"Dual roles of the caspase-11 non-canonical inflammasome in inflammatory bowel disease","volume":"108","author":"Yi","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2017.19","article-title":"Inflammasomes and intestinal inflammation","volume":"10","author":"Zmora","year":"2017","journal-title":"Mucosal Immunol"},{"key":"B165","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/cei.12617","article-title":"Altered expression of caspases-4 and -5 during inflammatory bowel disease and colorectal cancer: Diagnostic and therapeutic potential","volume":"181","author":"Flood","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252313058","article-title":"Inflammasomes in intestinal disease: mechanisms of activation and therapeutic strategies","volume":"25","author":"Scalavino","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01895","article-title":"Caspase-11 non-canonical inflammasomes in the lung","volume":"11","author":"Oh","year":"2020","journal-title":"Front Immunol"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1400501","article-title":"Protective role for caspase-11 during acute experimental murine colitis","volume":"194","author":"Oficjalska","year":"2015","journal-title":"J Immunol"},{"key":"B169","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.smim.2018.02.008","article-title":"The intestinal complement system in inflammatory bowel disease: Shaping intestinal barrier function","volume":"37","author":"Sina","year":"2018","journal-title":"Semin Immunol"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-021-00892-7","article-title":"Tipping the balance: intricate roles of the complement system in disease and therapy","volume":"43","author":"Pouw","year":"2021","journal-title":"Semin Immunopathol"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2025.04.007","article-title":"Targeting the NLRP3 inflammasome for inflammatory disease therapy","volume":"46","author":"Cabral","year":"2025","journal-title":"Trends Pharmacol Sci"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kem222","article-title":"Blocking the receptor for C5a in patients with rheumatoid arthritis does not reduce synovial inflammation","volume":"46","author":"Vergunst","year":"2007","journal-title":"Rheumatol (Oxford)"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2019.11.015","article-title":"Antibiotic prophylaxis in vaccinated eculizumab recipients who developed meningococcal disease","volume":"80","author":"Crew","year":"2020","journal-title":"J Infect"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2024.30.6.517","article-title":"Cost-effectiveness of eculizumab and efgartigimod for the treatment of anti\u2013acetylcholine receptor antibody\u2013positive generalized myasthenia gravis","volume":"30","author":"Lien","year":"2024","journal-title":"J Managed Care Specialty Pharmacy"},{"key":"B175","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1182\/blood-2025-2328","article-title":"New evidence that complement activation and NLRP3 inflammasome signaling work together to cause cytokine release syndrome after CAR-T cell therapy","volume":"146","author":"Wierzbicka","year":"2025","journal-title":"Blood"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12908","article-title":"Therapeutic modulation of inflammasome pathways","volume":"297","author":"Chauhan","year":"2020","journal-title":"Immunol Rev"},{"key":"B177","doi-asserted-by":"publisher","first-page":"10142","DOI":"10.1038\/s41467-024-54486-6","article-title":"Schwann cell C5aR1 co-opts inflammasome NLRP1 to sustain pain in a mouse model of endometriosis","volume":"15","author":"Titiz","year":"2024","journal-title":"Nat Commun"},{"key":"B178","doi-asserted-by":"publisher","first-page":"109043","DOI":"10.1016\/j.celrep.2021.109043","article-title":"NLRP6 in host defense and intestinal inflammation","volume":"35","author":"Venuprasad","year":"2021","journal-title":"Cell Rep"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.01.026","article-title":"NLRP6 inflammasome orchestrates the colonic host-microbial interface by regulating goblet cell mucus secretion","volume":"156","author":"Wlodarska","year":"2014","journal-title":"Cell"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.3390\/nu8010044","article-title":"Therapeutic potential to modify the mucus barrier in inflammatory bowel disease","volume":"8","author":"Sun","year":"2016","journal-title":"Nutrients"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2022.05.012","article-title":"Clinical heterogeneity of NLRP12-associated autoinflammatory diseases","volume":"10","author":"Li","year":"2023","journal-title":"Genes Dis"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2011.02.020","article-title":"Gain-of-function Pyrin mutations induce NLRP3 protein-independent interleukin-1beta activation and severe autoinflammation in mice","volume":"34","author":"Chae","year":"2011","journal-title":"Immunity"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaf1471","article-title":"Familial autoinflammation with neutrophilic dermatosis reveals a regulatory mechanism of pyrin activation. Science Translational Medicine","volume":"8","author":"Masters","year":"2016"},{"key":"B184","unstructured":"Eculizumab\n          \n          Edmonton (AB)\n          DrugBank (University of Alberta \/ Wishart Research Group)\n          DrugBank Online"},{"key":"B185","unstructured":"Ravulizumab\n          \n          Edmonton (AB)\n          DrugBank (University of Alberta \/ Wishart Research Group)\n          DrugBank Online"},{"key":"B186","unstructured":"Avacopan\n          \n          Edmonton (AB)\n          DrugBank (University of Alberta \/ Wishart Research Group)\n          DrugBank Online"},{"key":"B187","unstructured":"Pegcetacoplan\n          \n          Edmonton (AB)\n          DrugBank (University of Alberta \/ Wishart Research Group)\n          DrugBank Online"},{"key":"B188","unstructured":"Iptacopan\n          \n          Edmonton (AB)\n          DrugBank (University of Alberta \/ Wishart Research Group)\n          DrugBank Online"},{"key":"B189","unstructured":"Narsoplimab\n          \n          Edmonton (AB)\n          DrugBank (University of Alberta \/ Wishart Research Group)\n          DrugBank Online"},{"key":"B190","unstructured":"Sutimlimab\n          \n          Edmonton (AB)\n          DrugBank (University of Alberta \/ Wishart Research Group)\n          DrugBank Online"},{"key":"B191","unstructured":"Dapansutrile\n          \n          2025"},{"key":"B192","unstructured":"An open-label pilot study of VTX2735 in recurrent pericarditis\n          \n          Bethesda (MD)\n          National Library of Medicine (NLM), National Institutes of Health (NIH)\n          ClinicalTrials.gov"},{"key":"B193","unstructured":"A study to evaluate VTX2735 in patients with cryopyrin-associated periodic syndrome\n          \n          Bethesda (MD)\n          National Library of Medicine (NLM), National Institutes of Health (NIH)\n          ClinicalTrials.gov"},{"key":"B194","article-title":"Anakinra","volume-title":"DRUGBANK","year":""},{"key":"B195","article-title":"Canakinumab","volume-title":"DRUGBANK","year":""}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1778759\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T04:10:41Z","timestamp":1774843841000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1778759\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,30]]},"references-count":195,"alternative-id":["10.3389\/fimmu.2026.1778759"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1778759","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,30]]},"article-number":"1778759"}}